| |
| |
|
| Insider
Information: |
Bishop John E |
| Relationship: |
SVP, Chief Technology ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
157,253 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,252,637 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,253 |
|
|
| Total
Value |
$8,252,637 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Pharmaceuti... |
2016-05-19 |
157,253 |
2006-02-17 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
SVP, Chief Technology ... |
2022-10-14 |
0 |
2021-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
167 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-06-16 |
4 |
AS |
$13.69 |
$5,873 |
D/D |
(429) |
49,549 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-06-15 |
4 |
AS |
$14.00 |
$5,964 |
D/D |
(426) |
49,978 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-03-15 |
4 |
AS |
$13.94 |
$6,078 |
D/D |
(436) |
54,642 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2013-11-25 |
4 |
AS |
$17.77 |
$6,095 |
D/D |
(343) |
93,844 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-12-15 |
4 |
AS |
$14.42 |
$6,143 |
D/D |
(426) |
47,083 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2009-06-15 |
4 |
AS |
$9.00 |
$6,150 |
D/D |
(677) |
43,990 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-12-16 |
4 |
AS |
$14.83 |
$6,318 |
D/D |
(426) |
46,657 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-09-16 |
4 |
AS |
$15.10 |
$6,433 |
D/D |
(426) |
48,103 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-09-15 |
4 |
AS |
$15.51 |
$6,607 |
D/D |
(426) |
48,529 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-08-17 |
4 |
AS |
$21.67 |
$6,761 |
D/D |
(312) |
99,068 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-12-15 |
4 |
AS |
$15.92 |
$6,782 |
D/D |
(426) |
95,682 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-09-15 |
4 |
AS |
$17.38 |
$7,404 |
D/D |
(426) |
97,000 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2014-02-19 |
4 |
AS |
$17.86 |
$7,733 |
D/D |
(433) |
112,659 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-06-15 |
4 |
AS |
$18.17 |
$7,795 |
D/D |
(429) |
98,321 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2016-05-19 |
4 |
AS |
$10.20 |
$7,997 |
D/D |
(784) |
157,253 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-11-20 |
4 |
AS |
$17.75 |
$8,307 |
D/D |
(468) |
93,600 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2016-02-22 |
4 |
AS |
$9.71 |
$8,428 |
D/D |
(868) |
107,415 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-03-17 |
4 |
AS |
$14.59 |
$8,637 |
D/D |
(592) |
51,002 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-05-06 |
4 |
AS |
$19.05 |
$9,392 |
D/D |
(493) |
111,485 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-06-17 |
4 |
OE |
$12.58 |
$9,863 |
D/D |
784 |
111,164 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-11-19 |
4 |
AS |
$18.17 |
$10,430 |
D/D |
(574) |
94,068 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-08-20 |
4 |
AS |
$22.20 |
$10,434 |
D/D |
(470) |
95,109 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2007-12-17 |
4 |
AS |
$7.18 |
$10,770 |
D/D |
(1,500) |
28,500 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2009-02-23 |
4 |
AS |
$10.93 |
$11,804 |
D/D |
(1,080) |
35,595 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2013-02-15 |
4 |
AS |
$12.26 |
$11,892 |
D/D |
(970) |
91,166 |
0 |
- |
|
167 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
